John Pollok
Analyst · Stephens Inc
So on the capital side, I'd say a couple of things. I think as we mentioned really a year ago at the Investor Day, we didn't really know the impact of CECL then. We got a range out there now. I think back then we talked about maybe bringing the TCE range down a tad. I'm sure that's something we'll think about as we get into our capital planning at the end of the year, but we just got within that range. We still love the value of our company. We're going to continue to look at buybacks. From a dividend perspective, we're at the low end of our range, the 30% payout. So I think we can continue to focus on our new payout range, which, as you know, is 30% to 35%. So I think, we're in really good shape from a capital management standpoint. We have really haven't tapped the sub-debt market. Clearly, those prices out there today, Tyler, look very attractive. That's something we have in our tool if we wanted to do that. Next year from an accretion standpoint, the story has really hadn't changed a whole lot. And if you kind of go back and look at our slides, on Page 8, I think, we've tried to use this slide a lot, and this is kind of how we think about accretion going forward. Of course, this is based on September 30, these numbers will change at year-end, but Slide number 8 is a really good place to look at that. In fact, I use the slide countless times with investors to try to walk through that. So when you think about our noncredit impaired book, we've got a $24.2 million discount, that will continue to accrete through the income statement, that's a pretty easy one to see there. And then if you go back up on the credit impaired book, you can see our noncredit discount today is about $32.9 million. So assuming that our credit mark or our reserve is correct on the credit impaired, you would continue to see that accrete in. The next thing I would mention, as you know, today in our acquired loan book, we have everything set up in pools. And so we have to measure the weighted average life. So we've talked about it before, I still have loans in pools from our CBT transaction that we did back in 2010. So we have to remeasure the cash flows and kind of extend the accretion out. Well, we're going to burst our pools up. We're going to go more to a FAS 91 approach. And so as we do that, I think, our view today is you're going to see an acceleration of those accretion -- of that credit impaired accretion book to kind of come through in the income statement. So I think our view at the beginning is all things being equal today kind of where prepayment speeds, Tyler, I won't have to extend those weighted average lives out. So we think more accretion income will kind of flow through the income statement.